Bharat Biotech leads a CSIR-NMITLI supported project to develop human antibodies or COVID-19 therapy
On May 8, 2020, the Council of Scientific and Industrial Research (CSIR) under its flagship programme NMITLI announced it had sanctioned a project to develop human monoclonal antibodies as therapy for COVID-19 infections.
Tags:
Source: Bharat Biotech
Credit:
